TrialBMJ open2025

Interventional arterial chemotherapy versus sorafenib for advanced hepatocellular carcinoma in China: a health economic evaluation of open-label, randomised, phase 3 study.

Qi-Feng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.